Neogen Company Top Insiders
NEOG Stock | USD 5.33 0.10 1.91% |
Neogen's insiders are aggressively buying. The analysis of insiders' sentiment of trading Neogen stock suggests that almost all insiders are extremely bullish at this time. Neogen employs about 2.9 K people. The company is managed by 12 executives with a total tenure of roughly 29 years, averaging almost 2.0 years of service per executive, having 243.08 employees per reported executive.
John Adent CEO CEO President |
Robert Donofrio President Vice President - Food Safety Research and Development |
Insider Sentiment 100
Aggressively Buying
Selling | Buying |
Latest Trades
2025-05-12 | Aashima Gupta | Acquired 16000 @ 6.25 | View | ||
2025-04-24 | James C Borel | Acquired 35000 @ 4.89 | View | ||
2025-04-23 | Amy M Rocklin | Acquired 12500 @ 4.99 | View | ||
2025-04-22 | James P Tobin | Acquired 10000 @ 4.73 | View | ||
2025-04-10 | John Patrick Moylan | Acquired 10000 @ 5.07 | View | ||
2025-01-16 | John Edward Adent | Acquired 23035 @ 11.03 | View | ||
2024-10-11 | John Edward Adent | Acquired 14500 @ 13.8 | View | ||
2024-08-06 | James P Tobin | Acquired 3000 @ 16.86 | View |
Monitoring Neogen's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. Neogen Management Team Effectiveness
At this time, Neogen's Non Currrent Assets Other are most likely to increase significantly in the upcoming years. The Neogen's current Other Current Assets is estimated to increase to about 67.7 M, while Other Assets are projected to decrease to 1.09. Neogen's management efficiency ratios could be used to measure how well Neogen manages its routine affairs as well as how well it operates its assets and liabilities.The Neogen's current Common Stock Shares Outstanding is estimated to increase to about 261.4 M, while Net Loss is forecasted to increase to (25 M).
Neogen Workforce Comparison
Neogen is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 75,647. Neogen holds roughly 2,917 in number of employees claiming about 4% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.54) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. Neogen Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Neogen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Wainer Andrea F over a month ago Insider Trading | ||
Amy Rocklin over two months ago Disposition of 564 shares by Amy Rocklin of Neogen at 5.16 subject to Rule 16b-3 | ||
Woteki Catherine E over two months ago Acquisition by Woteki Catherine E of 5770 shares of Neogen at 5.17 subject to Rule 16b-3 | ||
Borel James C over three months ago Acquisition by Borel James C of 6075 shares of Neogen at 13.58 subject to Rule 16b-3 | ||
Boehm William T over three months ago Acquisition by Boehm William T of 236 shares of Neogen at 14.89 subject to Rule 16b-3 | ||
Bernard Thierry over six months ago Insider Trading | ||
Woteki Catherine E over six months ago Acquisition by Woteki Catherine E of 1776 shares of Neogen at 13.81 subject to Rule 16b-3 | ||
John Adent over six months ago Disposition of 38760 shares by John Adent of Neogen at 13.81 subject to Rule 16b-3 |
Neogen Notable Stakeholders
A Neogen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Neogen often face trade-offs trying to please all of them. Neogen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Neogen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
John Adent | CEO President | Profile | |
Robert Donofrio | Vice President - Food Safety Research and Development | Profile | |
Steven Quinlan | CFO, Principal Accounting Officer, VP and Secretary | Profile | |
John Moylan | Corporate VP | Profile | |
Bill Waelke | Head Relations | Profile | |
Dr MBA | Chief Officer | Profile | |
Julie Mann | VP Officer | Profile | |
Kevin Burke | Chief Officer | Profile | |
Amy Rocklin | Chief Secretary | Profile | |
David Naemura | Chief Officer | Profile | |
Sarah Demey | Administrative Manager | Profile | |
Douglas Jones | COO VP | Profile |
About Neogen Management Performance
The success or failure of an entity such as Neogen often depends on how effective the management is. Neogen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Neogen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Neogen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. Neogen Cp operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 2108 people.
Neogen Workforce Analysis
Traditionally, organizations such as Neogen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Neogen within its industry.Neogen Manpower Efficiency
Return on Neogen Manpower
Revenue Per Employee | 316.8K | |
Revenue Per Executive | 77M | |
Net Loss Per Employee | 3.2K | |
Net Loss Per Executive | 785.1K | |
Working Capital Per Employee | 149.1K | |
Working Capital Per Executive | 36.2M |
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |